v3 Template
B
Biora Therapeutics
Biotechnology / Healthcare
San Diego, USA
Founded
--
Employees
--
Total Funding
$113.7M
Funding Rounds
8
Last Funding
2024-10-29
About Biora Therapeutics
Biora Therapeutics, Inc. is focused on reimagining therapeutic delivery through innovative smart-pill technologies designed to deliver the right dose to the right place safely, aiming to improve the management of chronic diseases.
Products & Services
BioJet™ Oral Therapeutic Delivery Platform:A needle-free, oral delivery system for large molecules, designed to replace injections for better management of chronic diseases.
NaviCap™ Targeted Therapeutic Delivery Platform:A targeted oral delivery system for therapeutics, aimed at precise delivery within the gastrointestinal tract.
BT-600:A combination product of the NaviCap platform and tofacitinib, currently in Phase 1 clinical trials.
Specialties
Smart-pill technologies
Oral therapeutic delivery
Targeted drug delivery
Chronic disease management
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 3000000 MR: - FA: approximately $3 million FAN: 3000000 |
D: 2024-10-29 FD: 2024-10-29 |
- |
| 2 |
RT: Convertible Notes Financing T: - FT: Convertible Notes Financing |
A: 16000000 MR: - FA: up to $16M FAN: 16000000 |
D: 2024-08-12 FD: 2024-08-12 |
1 investors |
| 3 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 6000000 MR: - FA: 6,000,000 FAN: 6000000 |
D: 2024-04-03 FD: 2024-04-03 |
1 investors |
| 4 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 6000000 MR: - FA: approximately $6 million FAN: 6000000 |
D: 2024-04-01 FD: 2024-04-01 |
- |
| 5 |
RT: Convertible Debt T: - FT: Convertible Debt |
A: 16700000 MR: - FA: 16.7 million FAN: 16700000 |
D: 2023-12-18 FD: 2023-12-18 |
3 investors |
| 6 |
RT: Convertible Notes Exchange T: - FT: Convertible Notes Exchange |
A: 50000000 MR: - FA: $50 million FAN: 50000000 |
D: 2023-09-18 FD: 2023-09-18 |
1 investors |
| 7 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 8000000 MR: - FA: $8,000,000 FAN: 8000000 |
D: 2023-06-14 FD: 2023-06-14 |
1 investors |
| 8 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 8000000 MR: - FA: $8 million FAN: 8000000 |
D: 2023-06-13 FD: 2023-06-13 |
1 investors |
Registered Direct Offering
Latest
2024-10-29
$3.0M
Convertible Notes Financing
2024-08-12
$16.0M
Registered Direct Offering
2024-04-03
$6.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Biora Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- bioratherapeutics.com
- Industries
- Biotechnology / Healthcare
- Locations
- San Diego, USA
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro